HGH Fragment 176-191

HGH Fragment 176-191 is a stabilized fragment of the C-terminal portion of human growth hormone (amino acids 176-191). It is the parent compound of AOD-9604. Research focuses on fat metabolism and lipolysis without the growth-promoting or diabetogenic effects of full GH.

At a Glance

Summary: Stimulates lipolysis and fat oxidation through a GH-receptor-independent mechanism, targeting adipose tissue without affecting IGF-1, glucose metabolism, or growth. Mechanisms (reported/proposed across domains): Metabolic / fat reduction • Mimics the lipolytic region of human growth hormone, stimulating hormone-sensitive lipase activity in adipose tissue. • Promotes fat oxidation and...

Safety Profile

Investigational - Limited Data

Research Dosing

Dose: 250–500 mcg · Route: Subcutaneous (SC) · Frequency: 1–2× daily · Duration: 8–12 weeks

Categories

  • Research Only
  • Weight Loss
  • Fat Metabolism
  • Body Composition
  • Preclinical Evidence
  • Not FDA Approved
  • Daily Dosing

Related Peptides

The Leading Community for Trusted Peptide Research & Insights

Join a vibrant community sharing real peptide experiences, clinical research, and proven protocols. Data-backed, open, and censorship-free.